CRIXIVAN

Product NDC: 53808-0661
11-digit product format: 538080661
Labeler code: 53808
Product ID: 53808-0661_b34e05d5-b64b-42d0-a121-f5e21dfc3c1b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: indinavir sulfate
Dosage form: CAPSULE
Route: ORAL
Labeler: State of Florida DOH Central Pharmacy
Application: NDA020685
Marketing category: NDA
Marketing start: 2009-07-01
Marketing end: 0000-00-00
Substance: INDINAVIR SULFATE
Active strength: 400 mg/1
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	53808-0661		I	Inactivated by FDA		2026-10-12
excluded package	package	53808-0661	53808-0661-1	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53808-0661-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53808-0661-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53808-0661-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53808-0661-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53808-0661-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53808-0661-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53808-0661-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53808-0661-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53808-0661-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	53808-0661-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	53808-0661-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	53808-0661-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	53808-0661-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	53808-0661-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	53808-0661-1	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	53808-0661-1	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	53808-0661-1	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	53808-0661-1	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	53808-0661-1	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53808-0661-1	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53808-0661-1	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	53808-0661-1	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N020685-001	CRIXIVAN	INDINAVIR SULFATE	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13
N020685-003	CRIXIVAN	INDINAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13
N020685-005	CRIXIVAN	INDINAVIR SULFATE	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17
N020685-006	CRIXIVAN	INDINAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`5bbf6a4d5a75…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020685-001	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-003	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-005	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-006	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N020685-001	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-003	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-005	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-006	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-001	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-003	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-005	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-006	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020685-001	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-003	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-005	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-006	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020685-001	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-003	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-005	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-006	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020685-001	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-003	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-005	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-006	6689761	2021-02-10	U-554	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020685-001	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-003	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-005	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-006	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020685-001	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-003	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-005	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-006	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020685-001	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-003	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-005	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-006	6689761	2021-02-10	U-554	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
eed3583e-78db-412f-aba7-02811a2dc6a8	Product name	1	20150204

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53808-0661-1	2019-10-21	C162847	48780-1	956f9ecf-cda4-621f-e053-dbdaa90a74ad	CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53808-0661-1	CRIXIVAN	30 in 1 BLISTER PACK	CAPSULE	30		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
INDINAVIR SULFATE	ACTIVE INGREDIENT	771H53976Q	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
INDINAVIR	ACTIVE MOIETY	5W6YA9PKKH	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53808-0661	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3	Legacy NDC, 1 package rows	20100819_702727cb-3eff-425b-9573-031332849430.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
771H53976Q	INDINAVIR SULFATE	157810-81-6	INDINAVIR SULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
153128	Crixivan 400 MG Oral Capsule	PSN	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir sulfate 400 MG Oral Capsule	PSN	702727cb-3eff-425b-9573-031332849430	3
153128	indinavir 400 MG Oral Capsule [Crixivan]	SBD	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir 400 MG Oral Capsule	SCD	702727cb-3eff-425b-9573-031332849430	3
153128	Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3
153128	Crixivan 400 MG Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
53808-0661-1	53808066101	30 in 1 BLISTER PACK	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES	State of Florida DOH Central Pharmacy	2010-08-18	HUMAN PRESCRIPTION DRUG LABEL	3